Sikander Ailawadhi, MDAssociate Professor in the Division of Hematology Oncology, Department of MedicineMayo Clinic “We really think that access to the right healthcare is a problem. In this case, what I feel is that patients — we know these disparities exist — patients have to be their own advocates and at least ask for an opinion to get to the right myeloma expert — at least for an opinion.” Education Featured Programs Featured Programs Multiple Myeloma DHH Program, Sikander Ailawadhi MD, Saad Usmani MD FACP, DHH Video What Myeloma Health Disparities Exist for BIPOC Patients? Multiple Myeloma DHH Program, Sikander Ailawadhi MD, Saad Usmani MD FACP, DHH Video Multiple Myeloma DHH Program, Sikander Ailawadhi MD, Saad Usmani MD FACP, DHH Video Multiple Myeloma DHH Program, Sikander Ailawadhi MD, DHH Video Does Treatment Adherence in Myeloma Impact Outcomes? Multiple Myeloma DHH Program, Sikander Ailawadhi MD, DHH Video Multiple Myeloma DHH Program, Sikander Ailawadhi MD, DHH Video Multiple Myeloma DHH Program, Sikander Ailawadhi MD, DHH Video, disparities Disparities Around Health Technology Access for Subset of Myeloma Patients Multiple Myeloma DHH Program, Sikander Ailawadhi MD, DHH Video, disparities Multiple Myeloma DHH Program, Sikander Ailawadhi MD, DHH Video, disparities Multiple Myeloma DHH Program, Sikander Ailawadhi MD, DHH Video, American Society of Hematology 2020 Shaping Up to Be Big Year for Multiple Myeloma Treatment Multiple Myeloma DHH Program, Sikander Ailawadhi MD, DHH Video, American Society of Hematology Multiple Myeloma DHH Program, Sikander Ailawadhi MD, DHH Video, American Society of Hematology